COGNICURRENT

A new Swedish study shows that the HPV vaccine reduces the risk of cervical cancer for at least 18 years, with those vaccinated before age 17 experiencing nearly an 80% lower risk than unvaccinated women.

Cervical cancer is rapidly increasing in Canada, prompting health officials to call for more government action despite a long-term elimination plan.

Oslo University Hospital has recommended that 576 women undergo new HPV testing due to a technical error discovered in their screening equipment.

A Welsh man shares his near-fatal experience with cancer linked to HPV, highlighting the critical need for awareness among men regarding the virus's risks.

HPV prevalence leads to an increase in various cancer types in Estonia, particularly among younger demographics, highlighting the need for prevention efforts including vaccination.

A father from Cardiff reveals his near-fatal experience with HPV-related throat cancer to raise awareness among men about the risks of the virus.

An NGO project enables indigenous women in Xingu Indigenous Park, Mato Grosso, to be screened for cervical cancer through awareness and molecular testing.

The article emphasizes the critical role of colposcopy in diagnosing and treating cervical pathologies, particularly following abnormal Pap test results or HPV infections.

Acre experienced six cases of penis amputations due to cancer over the past five years, highlighting public health concerns related to hygiene and access to healthcare services.

HPV vaccination rates among schools in Far North Queensland have declined to 56%, leading to concerns over public health outcomes.

The Croatian Ministry of Health is proposing mandatory HPV vaccinations amid public health campaigns focusing on women's sexual health.

Recent research suggests testing menstrual blood for the human papillomavirus (HPV) could provide a more convenient and equally effective alternative for cervical cancer screening compared to traditional methods.

A new study shows that excessive use of feminine hygiene products may be detrimental to women's health by disrupting the balance of beneficial microbes in the vaginal ecosystem.

Brazil's nonavalent HPV vaccine has been updated to include protection against oropharyngeal cancer and other head and neck tumors associated with the virus.

Brazil's health regulatory agency Anvisa has approved a new indication for the HPV vaccine Gardasil 9 to prevent oropharyngeal, head, and neck cancers in individuals aged 9 to 45.

Doctors warn that head and neck cancer can develop silently with symptoms that may appear mild, emphasizing the importance of early diagnosis.

The Jigawa State government has assured its residents of the safety and protective benefits of the HPV vaccine, which has been integrated into the state's immunization program for girls aged 9-14.

Over 2,900 men in Brazil underwent penis amputations due to penile cancer between 2021 and 2025, highlighting hygiene and HPV vaccination as preventive measures.

A population study in Scotland shows that the HPV vaccination has long-lasting effects, with a sustained reduction in high-grade cervical lesions among over 270,000 women monitored for up to 12 years.

A new menstrual blood test has been developed that can detect HPV, potentially providing a convenient and non-invasive alternative to traditional cervical cancer screening methods.

A woman named Victoria, who showed no symptoms of cervical issues, discovered significant health changes through routine HPV testing, leading to early intervention and prevention of cervical cancer.

A new menstrual blood test has been developed to detect human papillomavirus (HPV), which is linked to cervical cancer, helping to improve screening for women who may avoid traditional tests due to discomfort or stigma.

Rwanda plans to introduce Gardasil 9, a new HPV vaccine, to enhance cancer protection and aims to eliminate cervical cancer by 2027, potentially becoming the first African nation to include it in its national immunization program.

A study published in The BMJ explores the potential of using menstrual blood for HPV testing as a less stressful alternative to traditional cervical screenings.

Chinese researchers have discovered a method to test women for HPV without inserting foreign objects into the body, using menstrual blood instead of traditional cell samples.

A reader's comment on the article discussing mandatory HPV vaccinations, highlighting that only Ukraine, Uganda, and Turkmenistan have such requirements.

The HPV vaccine is deemed a significant medical success, capable of preventing a majority of cervical cancer cases, and Australia aims to fully eliminate the disease by 2035 due to its effective national HPV vaccination program.

A football tournament in Zimbabwe highlighted cervical cancer awareness and promoted the HPV vaccine among 200 teenage girls from six African countries.

A vaccination campaign for boys born in 2008 to 2010 against the HPV virus is set to begin in schools, with free vaccinations offered and outreach planned for older cohorts.

The article discusses the rise in sexually transmitted infections in the Murcia region, highlighting the need for increased prevention efforts and awareness about HPV risks for males.

Despite the availability of effective vaccination, Poland has one of the lowest five-year survival rates for cervical cancer in Europe, with around 3,000 diagnoses and 1,700 deaths annually.

Specialists warn of a rising number of human papillomavirus (HPV) diagnoses and related lesions in men over 45, particularly those aged 60 to 70, who were not protected by systematic vaccination.

A large study indicates that HPV vaccination is highly effective in lowering the risk of cervical cancer among vaccinated girls.